The Metabolic Classroom with Dr. Ben Bikman

Questions?📢 Ask Dr. Bikman’s Digital Mind (multilingual):https://benbikman.com/ben-bikmans-digital-ai-mind📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.comSummary:Dr. Ben Bikman explains the surprising relationship between potassium, insulin, and blood sugar control. Potassium is an essential mineral that helps cells maintain their electrical activity, and insulin plays an important role in moving potassium from the bloodstream into cells. But the relationship works both ways: when potassium levels become too low, the pancreas may struggle to release enough insulin, potentially causing blood sugar to rise.Ben also explores the role of aldosterone, a hormone that tells the kidneys to retain sodium while releasing potassium. When aldosterone levels are too high, potassium loss can increase, insulin production may suffer, and blood pressure can rise. He reviews research linking lower potassium levels—even within the normal laboratory range—to an increased risk of developing type 2 diabetes.The lecture then examines what happens during fasting and carbohydrate restriction. As insulin falls, the kidneys release more sodium and water, while changes in aldosterone can increase potassium loss. Ben explains why this matters especially when ending a prolonged fast: a sudden insulin spike from a carbohydrate-heavy meal can rapidly move potassium into cells, potentially causing dangerous electrolyte imbalances.The central takeaway is that potassium deserves more attention in metabolic health. Eating potassium-rich whole foods, maintaining appropriate electrolyte balance, and being thoughtful about how prolonged fasts are ended may help support healthy insulin function and blood sugar regulation.References:For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.comNOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. Hosted on Acast. See acast.com/privacy for more information.

Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual):https://benbikman.com/ben-bikmans-digital-ai-mind📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.comDr. Bikman explains why micronized progesterone should not be confused with the synthetic progestins historically used in many hormone therapies. Micronized progesterone is chemically identical to the hormone produced naturally by a woman’s ovaries, while synthetic progestins can also activate cortisol- or testosterone-related receptors, potentially affecting insulin sensitivity, blood lipids, and other aspects of metabolic health.Ben reviews clinical evidence showing that micronized progesterone can effectively protect the uterine lining when estrogen is used while preserving more of estrogen’s favorable metabolic effects. Oral micronized progesterone is also converted into allopregnanolone, which enhances the brain’s calming GABA signaling and may improve sleep. Better sleep itself can support insulin sensitivity, while progesterone may also reduce hot flashes and night sweats that interfere with sleep.The safety evidence is also encouraging. Compared with some synthetic progestins, micronized progesterone appears more favorable with respect to blood clots, breast cancer risk, and metabolic markers. Ben’s overall conclusion is that for women using menopausal hormone therapy who need progesterone to protect the uterus, micronized progesterone appears to be a metabolically favorable partner to estrogen.References:For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.comNOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. Hosted on Acast. See acast.com/privacy for more information.

Question?📢 Ask Dr. Bikman’s Digital Mind (multilingual):https://benbikman.com/ben-bikmans-digital-ai-mind📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.comTopic:Continuous glucose monitoring shows how the body handles glucose, but it cannot reveal how much insulin was required to produce that glucose response. By continuously measuring ketones alongside glucose, the new dual sensor may provide an indirect window into insulin activity, fat burning, and metabolic flexibility while also helping people with diabetes detect dangerous ketone elevations earlier.Summary:Dr. Ben Bikman explores a new wearable that continuously measures both glucose and ketones. Unlike a traditional continuous glucose monitor, Abbott’s Libre Duo can track beta-hydroxybutyrate (BHB) alongside glucose, providing another window into what is happening metabolically. For people with diabetes, continuous ketone monitoring could provide earlier warning of dangerous ketoacidosis, particularly in people with type 1 diabetes or those using SGLT2 inhibitors.Ben explains why ketones provide information that glucose alone cannot. Because insulin strongly suppresses fat release, fat oxidation, and ketone production, changes in ketones can serve as an indirect indicator of insulin activity. A seemingly normal glucose response can therefore hide the fact that the body required a large amount of insulin to produce it, while watching glucose and ketones together may reveal more about how readily the body transitions between glucose and fat metabolism.Ben sees potential value beyond diabetes as well. During fasting or carbohydrate restriction, glucose would generally fall while ketones rise; after a carbohydrate-rich meal, the opposite occurs. Tracking both signals continuously could therefore offer a more complete picture of metabolic flexibility and help people better understand their individual responses to food, fasting, and other metabolic changes.References:For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.comAlso, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mindNOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. Hosted on Acast. See acast.com/privacy for more information.